Skip to main content

BARCLAYS PLC

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 312069 LONDON, X0

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
669,601
+291.2% QoQ
Ownership
0.580%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TERN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 100
2026-03-31 669,601
2025-12-31 171,186
2025-09-30 130,391
2025-06-30 244,637
2025-03-31 653,037
2024-12-31 704,371
2024-09-30 94,902
2024-09-30 34,400
2024-06-30 195,442
2024-03-31 248,304
2023-12-31 84,582
2023-09-30 54,327
2023-06-30 262,918
2023-03-31 534,760
2022-12-31 516,739
2022-09-30 659,098
2022-06-30 13,125
2022-03-31 15,352